An echocardiogram does not directly detect atrial fibrillation. The irregular heart rhythm that defines afib is diagnosed with an electrocardiogram (EKG), which records electrical activity. An echocardiogram uses ultrasound to create images of the heart’s structure and blood flow. That said, an echo reveals critical information about afib that an EKG cannot: the size of your heart chambers, how well they pump, whether blood is pooling dangerously, and what structural problems may be fueling the arrhythmia in the first place.
Why an Echo Can’t Diagnose the Rhythm Itself
Atrial fibrillation is fundamentally an electrical problem. The upper chambers of the heart fire chaotic electrical signals instead of beating in an organized pattern. An EKG picks this up by measuring the electrical impulses traveling through heart tissue, and it remains the standard tool for confirming afib. An echocardiogram, by contrast, captures moving images of the heart’s physical structures. It can show the consequences of afib and the conditions that promote it, but it cannot record the disorganized electrical signals that define the arrhythmia.
What an Echo Does Show in Afib Patients
Once afib is diagnosed, an echocardiogram is one of the first tests ordered because it answers questions an EKG simply can’t. Several structural findings on an echo are closely tied to atrial fibrillation.
Enlarged Left Atrium
The left atrium, the upper-left chamber of the heart, is frequently enlarged in people with afib. A normal left atrium measures roughly 33 to 40 millimeters across. In patients with afib caused by valve disease, the average diameter stretches to about 47 mm, and it can reach as large as 73 mm. Even in afib unrelated to valve problems, the average left atrial size runs around 42 mm. This enlargement matters because a bigger atrium creates more tissue where abnormal electrical circuits can form, making afib more likely to start and harder to stop.
Doctors also measure left atrial volume indexed to body size (called LAVI). A normal range is 16 to 34 ml/m². Patients with mildly enlarged measurements (35 to 41 ml/m²) tend to respond better to treatments that restore normal rhythm. Those with moderate enlargement (42 to 48 ml/m²) or severe enlargement (above 48 ml/m²) have significantly higher rates of afib returning after treatment. In fact, each unit increase in LAVI raises the risk of afib recurrence by about 6%. This single echo measurement often shapes the entire treatment strategy.
Missing “Atrial Kick”
A specialized echo technique called Doppler imaging tracks the speed and direction of blood flowing through the heart. In a normal heart, when the left atrium contracts, it produces a distinct wave of blood flow through the mitral valve, sometimes called the A-wave or “atrial kick.” In afib, this wave disappears because the atrium is quivering instead of contracting. This missing A-wave is visible on the echo and confirms that the atrium has lost its mechanical pumping function, not just its electrical rhythm. The loss of atrial kick reduces overall cardiac output and can drop the amount of blood the heart pumps with each beat.
Interestingly, even after a normal rhythm is restored on the EKG, the A-wave sometimes fails to return on the echo. Patients whose atrium still isn’t contracting despite looking electrically normal are at high risk for slipping back into afib. In those cases, the echo finding can redirect treatment toward controlling heart rate rather than repeatedly attempting to restore rhythm.
Reduced Pumping Strength
Ejection fraction, the percentage of blood the heart pushes out with each beat, is a core measurement on every echo. Persistent afib can weaken the heart muscle over time through a process called tachycardia-induced cardiomyopathy, where prolonged rapid heart rates gradually damage the muscle fibers. In one study of 810 afib patients, about 35% had a persistent drop in ejection fraction, while roughly 9% had a temporary reduction that recovered once normal rhythm returned. Patients with a persistent drop faced roughly double the risk of being hospitalized for heart failure within a year compared to those whose ejection fraction stayed normal.
This distinction between temporary and lasting damage is something only serial echocardiograms can track. If your ejection fraction bounces back after rhythm is restored, the prognosis is considerably better, though recurrence of the fast rhythm can cause a rapid decline again.
Valve Problems
Echocardiograms frequently reveal mitral valve regurgitation in afib patients, where the valve between the left atrium and left ventricle leaks backward. This leak raises pressure in the left atrium, stretches the chamber, increases scarring in atrial tissue, and slows the electrical signals traveling through it. All of these changes create a self-reinforcing cycle: valve disease promotes afib, and afib can worsen valve leakage. The echo identifies this loop so it can be addressed.
Two Types of Echo for Afib
The standard echocardiogram, called transthoracic (TTE), presses an ultrasound probe against your chest wall. It provides a good view of chamber sizes, valve function, and pumping strength. For most afib patients, this is the echo they’ll receive first.
A transesophageal echocardiogram (TEE) involves a thin probe passed down the throat into the esophagus, which sits directly behind the heart. This gives a much sharper view of certain structures, particularly the left atrial appendage, a small pouch in the left atrium where blood clots tend to form during afib. Standard chest-wall imaging simply cannot produce reliable images of this appendage. TEE is considered the gold standard for detecting clots in this location.
Your doctor will typically order a TEE before certain procedures, such as cardioversion (a controlled electrical shock to reset heart rhythm) or catheter ablation, to make sure no clot is hiding in the appendage. Dislodging an undetected clot during these procedures could cause a stroke.
“Smoke” in the Heart
During a TEE, doctors sometimes see swirling, smoke-like patterns inside the left atrium or its appendage. This phenomenon, called spontaneous echo contrast, indicates sluggish blood flow. It appears as hazy, dynamic echoes drifting through the chamber. In patients with afib not caused by valve disease, the presence of this “smoke” predicts future blood clots, stroke, and death. It is present in nearly all patients who already have a clot in the left atrium. Identifying it can help determine whether a patient needs more aggressive blood-thinning medication, even if no clot is visible yet.
How the Echo Shapes Your Treatment
The specific findings on an echocardiogram directly influence which path your afib treatment takes. A mildly enlarged left atrium with a normal ejection fraction points toward rhythm control strategies, where the goal is restoring and maintaining a normal heartbeat. A severely enlarged atrium with significant valve disease suggests that returning to normal rhythm may not be sustainable, tilting the approach toward rate control, which focuses on keeping the heart from beating too fast without necessarily fixing the rhythm.
Ejection fraction measurements determine whether heart failure medications need to be added. The presence or absence of clots or “smoke” on a TEE dictates timing for procedures and the intensity of blood-thinning therapy. In many cases, the echo provides more actionable information for managing afib than the EKG that diagnosed it.